About Johnson & Johnson
Johnson & Johnson is a health care company based in New Brunswick, New Jersey, that researches, makes, and sells medicines and medical technology. It works through two segments: Innovative Medicine, covering prescription drugs in areas such as cancer, immune disorders, and neuroscience, and MedTech, covering devices for surgery, orthopedics, heart care, and vision. Joaquin Duato serves as chief executive. The company was founded in 1886 by Robert Wood Johnson and his brothers. In 2023 it spun off its consumer health business as Kenvue, leaving it focused on medicines and medical devices.
Blockchain Association urges Congress to pass crypto tax rules before the clock runs out
The push for updated crypto tax rules highlights the urgent need for regulatory clarity to support innovation and protect investors in the digital economy.
Mastercard unveils Stablecoin Security tool to screen payments for fraud and sanctions risk
Mastercard's tool could enhance trust in stablecoin transactions, potentially accelerating their adoption and integration into mainstream finance.
KKR-backed Catalio Capital seeks $500 million for AI healthcare startups
Catalio's fundraising efforts highlight growing investor confidence in AI-driven healthcare innovations, potentially reshaping the industry landscape.
Franklin Templeton CEO pitches short-term Big Tech debt as the smarter AI bet
Short-term Big Tech debt offers a strategic AI investment, balancing risk and reward amid rapid tech evolution and potential economic shifts.
Isomorphic Labs reportedly seeks funding at a valuation of at least $40 billion
Isomorphic Labs' valuation surge highlights the growing investor confidence in AI-driven drug discovery, despite lacking clinical data.
Franklin Templeton CEO says rival tokenized funds miss the point of blockchain
The shift towards native blockchain-based funds could redefine financial efficiency, offering real-time data and significantly reduced costs.
A sourced map of Johnson & Johnson's relationships is on the way.
Partners, competitors and related assets, each link independently verified and source-linked before it appears here.
The Crypto Briefing podcast is on the way.
Conversations on Johnson & Johnson and the wider market, hosted by our team, will appear here once episodes are live.